Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes. From Wikipedia
A recent study reveals that lixisenatide, a diabetes medication, may help mitigate the progression of Parkinson's disease, though side effects and the need for further research remain.